Arkolith/Insider Trading/EW/Form 4

Bobo Donald E JR

CVP,Strategy/Corp DevelopmentEdwards Lifesciences Corp (EW) · full profile →Form 4 · filed May 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.5M
Net Open-Market Flow
-$1.5M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2026Sell(S)10K$82.07$818K23K
May 15, 2026Sell(S)8K$81.82$655K31K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001225208-26-005463) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML